Showing results (61-70 of 447) with videos related to
Sort By:
Pageof 45
Heart Rhythm|April 27, 2005
Cost-effectiveness of physiologic pacing: results of the Canadian Health Economic Assessment of Physiologic PacingBernie J O'Brien, Gordon Blackhouse, Ron Goeree, et al.American Heart Journal|August 15, 2002
Quality of life in the Canadian Implantable Defibrillator Study (CIDS)Jane Irvine, Paul Dorian, Brian Baker, et al.European Heart Journal|August 6, 2010
Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-WRaffaele De Caterina, Stuart J Connolly, Janice Pogue, et al.Journal of the American College of Cardiology|November 27, 2007
Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W SubstudyStefan H Hohnloser, Dimitri Pajitnev, Janice Pogue, et al.Thrombosis Research|November 26, 2009
Underuse of evidence-based warfarin dosing methods for atrial fibrillation patientsRobby Nieuwlaat, Lucy Barker, Yang-Ki Kim, et al.European Heart Journal|March 15, 2013
Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa)Stuart J Connolly, John Eikelboom, Paul Dorian, et al.Circulation|December 8, 2010
Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT)Paul Dorian, Stefan H Hohnloser, Kevin E Thorpe, et al.Journal of Cardiovascular Electrophysiology|November 23, 2007
Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutterStefan H Hohnloser, Stuart J Connolly, Harry J G M Crijns, et al.European Journal of Heart Failure|July 12, 2013
Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trialJorge Ferreira, Michael D Ezekowitz, Stuart J Connolly, et al.Current Cardiology Reports|September 10, 2020
Permanent Bilateral Carotid Filters for Stroke Prevention in Atrial FibrillationTom De Potter, Ofer Yodfat, Guy Shinar, et al.Pageof 45